Adversomics

A new paradigm for vaccine safety and design

Jennifer A. Whitaker, Inna G. Ovsyannikova, Gregory A. Poland

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Despite the enormous population benefits of routine vaccination, vaccine adverse events (AEs) and reactions, whether real or perceived, have posed one of the greatest barriers to vaccine acceptance-and thus to infectious disease prevention-worldwide. A truly integrated clinical, translational, and basic science approach is required to understand the mechanisms behind vaccine AEs, predict them, and then apply this knowledge to new vaccine design approaches that decrease, or avoid, these events. The term 'adversomics' was first introduced in 2009 and refers to the study of vaccine adverse reactions using immunogenomics and systems biology approaches. In this review, we present the current state of adversomics research, review known associations and mechanisms of vaccine AEs/reactions, and outline a plan for the further development of this emerging research field.

Original languageEnglish (US)
Pages (from-to)935-947
Number of pages13
JournalExpert Review of Vaccines
Volume14
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Vaccines
Safety
Systems Biology
Research
Communicable Diseases
Vaccination
Population

Keywords

  • drug-related side effects and adverse reactions
  • genetic association studies
  • genomics
  • immunogenetics
  • individualized medicine
  • polymorphism
  • single nucleotide
  • systems biology
  • vaccination
  • vaccines
  • viral vaccines

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine

Cite this

Adversomics : A new paradigm for vaccine safety and design. / Whitaker, Jennifer A.; Ovsyannikova, Inna G.; Poland, Gregory A.

In: Expert Review of Vaccines, Vol. 14, No. 7, 01.07.2015, p. 935-947.

Research output: Contribution to journalArticle

Whitaker, JA, Ovsyannikova, IG & Poland, GA 2015, 'Adversomics: A new paradigm for vaccine safety and design', Expert Review of Vaccines, vol. 14, no. 7, pp. 935-947. https://doi.org/10.1586/14760584.2015.1038249
Whitaker, Jennifer A. ; Ovsyannikova, Inna G. ; Poland, Gregory A. / Adversomics : A new paradigm for vaccine safety and design. In: Expert Review of Vaccines. 2015 ; Vol. 14, No. 7. pp. 935-947.
@article{25fe89d3aa9c465cb9fa179a0bceb5f2,
title = "Adversomics: A new paradigm for vaccine safety and design",
abstract = "Despite the enormous population benefits of routine vaccination, vaccine adverse events (AEs) and reactions, whether real or perceived, have posed one of the greatest barriers to vaccine acceptance-and thus to infectious disease prevention-worldwide. A truly integrated clinical, translational, and basic science approach is required to understand the mechanisms behind vaccine AEs, predict them, and then apply this knowledge to new vaccine design approaches that decrease, or avoid, these events. The term 'adversomics' was first introduced in 2009 and refers to the study of vaccine adverse reactions using immunogenomics and systems biology approaches. In this review, we present the current state of adversomics research, review known associations and mechanisms of vaccine AEs/reactions, and outline a plan for the further development of this emerging research field.",
keywords = "drug-related side effects and adverse reactions, genetic association studies, genomics, immunogenetics, individualized medicine, polymorphism, single nucleotide, systems biology, vaccination, vaccines, viral vaccines",
author = "Whitaker, {Jennifer A.} and Ovsyannikova, {Inna G.} and Poland, {Gregory A.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1586/14760584.2015.1038249",
language = "English (US)",
volume = "14",
pages = "935--947",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - Adversomics

T2 - A new paradigm for vaccine safety and design

AU - Whitaker, Jennifer A.

AU - Ovsyannikova, Inna G.

AU - Poland, Gregory A.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Despite the enormous population benefits of routine vaccination, vaccine adverse events (AEs) and reactions, whether real or perceived, have posed one of the greatest barriers to vaccine acceptance-and thus to infectious disease prevention-worldwide. A truly integrated clinical, translational, and basic science approach is required to understand the mechanisms behind vaccine AEs, predict them, and then apply this knowledge to new vaccine design approaches that decrease, or avoid, these events. The term 'adversomics' was first introduced in 2009 and refers to the study of vaccine adverse reactions using immunogenomics and systems biology approaches. In this review, we present the current state of adversomics research, review known associations and mechanisms of vaccine AEs/reactions, and outline a plan for the further development of this emerging research field.

AB - Despite the enormous population benefits of routine vaccination, vaccine adverse events (AEs) and reactions, whether real or perceived, have posed one of the greatest barriers to vaccine acceptance-and thus to infectious disease prevention-worldwide. A truly integrated clinical, translational, and basic science approach is required to understand the mechanisms behind vaccine AEs, predict them, and then apply this knowledge to new vaccine design approaches that decrease, or avoid, these events. The term 'adversomics' was first introduced in 2009 and refers to the study of vaccine adverse reactions using immunogenomics and systems biology approaches. In this review, we present the current state of adversomics research, review known associations and mechanisms of vaccine AEs/reactions, and outline a plan for the further development of this emerging research field.

KW - drug-related side effects and adverse reactions

KW - genetic association studies

KW - genomics

KW - immunogenetics

KW - individualized medicine

KW - polymorphism

KW - single nucleotide

KW - systems biology

KW - vaccination

KW - vaccines

KW - viral vaccines

UR - http://www.scopus.com/inward/record.url?scp=84931830141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931830141&partnerID=8YFLogxK

U2 - 10.1586/14760584.2015.1038249

DO - 10.1586/14760584.2015.1038249

M3 - Article

VL - 14

SP - 935

EP - 947

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 7

ER -